Sales decline 47.97% to Rs 4.74 crore
Net Loss of Earum Pharmaceuticals reported to Rs 0.72 crore in the quarter ended March 2022 as against net loss of Rs 0.99 crore during the previous quarter ended March 2021. Sales declined 47.97% to Rs 4.74 crore in the quarter ended March 2022 as against Rs 9.11 crore during the previous quarter ended March 2021.For the full year,net profit rose 2366.67% to Rs 2.22 crore in the year ended March 2022 as against Rs 0.09 crore during the previous year ended March 2021. Sales declined 48.78% to Rs 21.04 crore in the year ended March 2022 as against Rs 41.08 crore during the previous year ended March 2021.
ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales4.749.11 -48 21.0441.08 -49 OPM %-111.39-14.60 --21.01-18.89 - PBDT0.14-0.99 LP 3.200.24 1233 PBT0.14-0.99 LP 3.080.12 2467 NP-0.72-0.99 27 2.220.09 2367
Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
